Episode

Best of Lung Cancer Science - European Society for Medical Oncology (ESMO)

Podcast
Thinking Thoracic
Published
Feb 18, 2026
Duration seconds
4272
Processing state
not_requested
Canonical source
https://thinkingthoracic.podbean.com/e/best-of-lung-cancer-science-european-society-for-medical-oncology-esmo/
Audio
https://mcdn.podbean.com/mf/web/76yri2fcu6gxnrf3/25-12_-_EP4_-_Jessica_Christine_Audio_Only_1_7h3ib.mp3
JSON
/v1/public/podcasts/thinking-thoracic-7116337/episodes/best-of-lung-cancer-science-european-society-for-medical-oncology-esmo
Markdown
/podcast/thinking-thoracic-7116337/best-of-lung-cancer-science-european-society-for-medical-oncology-esmo.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/thinking-thoracic-7116337/episodes/best-of-lung-cancer-science-european-society-for-medical-oncology-esmo/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/thinking-thoracic-7116337/best-of-lung-cancer-science-european-society-for-medical-oncology-esmo.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Jessica Donington, MD, and Christine Bestvina, MD, join Dr. Gillaspie to unpack key lung cancer advances from ESMO, including adjuvant ALK inhibition (ALINA, ELEVATE), perioperative immunotherapy (KEYNOTE-671), and the expanding neoadjuvant space in borderline resectable disease.